XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows used in operating activities:    
Net loss $ (9,045) $ (10,755)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 1,575 1,879
Operating lease right-of-use asset 341 341
Depreciation 77 56
Amortization of premium on marketable debt securities (71) 410
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (6,145) (1,186)
Other assets 58 78
Accounts payable 2,495 (413)
Accrued expenses (1,841) (1,039)
Operating lease liabilities (332) (332)
Net cash used in operating activities (12,888) (10,961)
Cash flows from investing activities:    
Purchase of marketable debt securities (12,186) (12,415)
Proceeds from maturity and redemption of marketable debt securities 22,052 13,171
Purchase of property and equipment (6) (11)
Net cash provided by investing activities 9,860 745
Cash flows from financing activities:    
Repurchase of shares in connection with settlement of RSUs (64) (72)
Net cash used in financing activities (64) (72)
Net decrease in cash and cash equivalents and restricted cash (3,092) (10,288)
Cash and cash equivalents and restricted cash - beginning of year 24,872 36,469
Cash and cash equivalents and restricted cash - end of period 21,780 26,181
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 21,035 25,436
Restricted cash, non-current 745 745
Cash and cash equivalents and restricted cash $ 21,780 $ 26,181